Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Licensing Deals Still Backloaded In 2013, But Biotechs Could Gain Leverage

Jan 27 2014

• By Paul Bonanos

Related Content

In 2012, Buyer’s Market Made Alliances Rarer

Jan 07 2013

Pharmas Among Biggest Cash Hoarders, Moody’s Finds

Mar 20 2013

No Longer Aiming To Partner At Proof-of-Concept, Flexion Raises $20M For Late-Stage Trials

Dec 04 2012

Biopharma M&A In An Era Of Elusive Growth, Capital Triage, and New Competitors

Jun 19 2013

Related Companies

Pfizer Inc.

Amgen, Inc.

Johnson & Johnson

Merck & Co., Inc.

Bristol Myers Squibb Company

OncoMed Pharmaceuticals, Inc.

MorphoSys AG

Genetix Biotherapeutics

Array BioPharma, Inc.

Flexion Therapeutics, Inc.

Gilead Sciences, Inc.

Jazz Pharmaceuticals plc

Aerial BioPharma, LLC

Alexion Pharmaceuticals Inc.

Moderna, Inc.

Alnylam Pharmaceuticals Inc.

Sanofi Genzyme

Additional Topics

Deals BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window